Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 59
-2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

An initial exploration of in-situ underwater genetic sequencing

Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

Biological control of the mosquito Aedes aegypti

The mosquito A. aegypti is the main vector for dengue and zika viruses. This mosquito has developed resistance...

How has the Asian Tiger Mosquito invaded the world?

The Asian Tiger Mosquito transmits human disease viruses, such as Dengue and Chikungunya, and is an invasive...

Backer Badge Funded